Results 141 to 150 of about 10,542 (222)

Blood biomarkers of seizures in epilepsy: machine learning reveals altered plasma proteome. [PDF]

BMJ Neurol Open
Akel S, Ashtiani SH, Sarangdhar MA, Axelsson M, Zelano J.   +4 more
europepmc   +1 more source

Kidney ADP-Ribosyl Cyclase Inhibitors as a Therapeutic Tool for Diabetic Nephropathy [PDF]

, 2012
Uh-Hyun Kim
core   +2 more sources

CD56 expression modulates NAD+ metabolic landscape and predicts sensitivity to anti-CD38 therapies in multiple myeloma. [PDF]

Blood Cancer J
Giorgetti G, Maroto-Martin E, Soncini D, Fenoglio D, Becherini P, Benzi A, Ravera S, Traverso I, Ladisa F, Lai F, Rivoli G, Truffelli D, Nahimana A, Cagnetta A, Guolo F, Uras CRM, Schavgoulidze A, Fong Ng J, Nencioni A, Bruzzone S, Munshi NC, Lemoli RM, Fulciniti M, Cea M.   +23 more
europepmc   +1 more source

Acute Rejection With DSA-Negative Severe Microvascular Inflammation in a Kidney Transplant Recipient With an Isolated DPB1*04-Mismatch Successfully Stabilised With Daratumumab. [PDF]

HLA
Knödl L, Büttner-Herold M, Götz M, Luber M, Spriewald B, Oellerich M, Beck J, Banas B, Zecher D.   +8 more
europepmc   +1 more source

Synthesis of site-specific Fab-drug conjugates using ADP-ribosyl cyclases. [PDF]

Protein Sci
Kim HS, Hariri K, Zhang XN, Chen LC, Katz BB, Pei H, Louie SG, Zhang Y.   +7 more
europepmc   +1 more source

Editorial: Adenine nucleotides in immunity and inflammation. [PDF]

Front Immunol
Müller CE, Bruzzone S, Guse AH.
europepmc   +1 more source

Anthrax Toxin: A Pioneer of Targeted Protein Toxins. [PDF]

Toxins (Basel)
Richter S, Schmidt G.
europepmc   +1 more source

Redesign of Schistosoma mansoni NAD+ catabolizing enzyme: active site H103W mutation restores ADP-ribosyl cyclase activity. [PDF]

Biochemistry, 2006
Kuhn I, Kellenberger E, Rognan D, Lund FE, Muller-Steffner H, Schuber F.   +5 more
europepmc   +1 more source

Diazirine-AIOC-NAADP, a Clickable-Photoactive NAADP Analog for Sea Urchin NAADP Binding Proteins. [PDF]

ACS Chem Biol
Zhang Y, Guan Z, Gadient JN, Kumar S, Gunaratne G, Walseth TF, Marchant JS, Wall KA, Slama JT.   +8 more
europepmc   +1 more source

Multiprong CD38 targeting to enhance anti-PD1 immune checkpoint blockade efficacy. [PDF]

Oncoimmunology
Vijayan VV, Nair PG, Gujar S.
europepmc   +1 more source